Skip to content
Research Article Open access CC BY 4.0

Comparative Analysis of Cervical Human Papillomavirus DNA Testing and Cytological Findings among Women Presenting for “Pap” Smear in a Tertiary Health Centre in Northern Nigeria

M. M. Manga, A. Fowotade, Y. M. Abdullahi, A. U. El-Nafaty, S. Adamu, A. D. Bojude, H. U. Pindiga, R. A. Bakare, A. O. Osoba

International Journal of TROPICAL DISEASE & Health · pp. 1–8 · Published 17 Dec 2015

10.9734/IJTDH/2016/23084

Abstract

im: This study was conducted to compare different cytological findings with cervical HPV infection among women presenting for cervical cancer screening in Gombe north-eastern Nigeria. Study Design: It is a hospital based cross-sectional study. Place and Duration of Study: Departments of Obstetrics/Gynaecology and Histopathology Federal Teaching Hospital Gombe (FTHG) Nigeria, between August 2013 and May 2014. Methodology: Two hundred and nine (209) women were subjected to liquid-based cervical cytology and HPV DNA testing. Results: Of the 209 participants, cytological findings were normal in 126 (61.6%) women while 80 (39.0%) had abnormal features. Three (1.4%) respondents had unsatisfactory smears. The observed abnormal cytological features include HPV changes 30 (14.4%), HPV changes with inflammation 2 (1.0%), inflammatory changes alone 36 (17.3%), Low Squamous Intraepithelial Lesion; LSIL 3 (1.4%), High Squamous Intraepithelial Lesion; HSIL 5 (2.4%) and malignant changes 3 (1.4%). Positive HPV DNA testing was detected among 100 (48.1%) of the participants. Almost half 60 (47.6%) of the women with normal cytology were positive for HPV. Among women with cytologically detected HPV changes, only 16 (50%) were also HPV DNA positive. The sensitivity and specificity of cervical cytology in detecting HPV infection was 16.2% and 85.0% respectively. Conclusion: This study reports a very low sensitivity but relatively high specificity of cytology in detecting cervical HPV infection. It further justifies the need for introduction of HPV DNA testing to improve efficiency and maximise the sensitivity of cytology based cervical cancer screening for women above 30 years.

Cervical cancer cytology human papillomavirus DNA testing Nigeria

References (20)

  1. 1 Human papillomavirus and cervical cancer [DOI]
  2. 2 Human Papillomavirus Testing in the Prevention of Cervical Cancer [DOI]
  3. 3 Persistence and load of high‐risk HPV are predictors for development of high‐grade cervical lesions: A longitudinal French cohort study [DOI]
  4. 4 HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial [DOI]
  5. 5 Oncogenic activities of human papillomaviruses [DOI]
  6. 6 An association of cervical inflammation with high-grade cervical neoplasia in women infected with oncogenic human papillomavirus (HPV).
  7. 7 A comparison of HPV DNA testing and liquid based cytology over three rounds of primary cervical screening: Extended follow up in the ARTISTIC trial [DOI]
  8. 8 Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial [DOI]
  9. 9 Cervical cancer screening: on the way to a shift from cytology to full molecular screening [DOI]
  10. 10 Cytological regression and clearance of high-risk human papillomavirus in women with an abnormal cervical smear [DOI]
  11. 11 Touchdown General Primer (GP5+/GP6+) PCR and optimized sample DNA concentration support the sensitive detection of human papillomavirus [DOI]
  12. 12 The age‐specific prevalence of human papillomavirus and risk of cytologic abnormalities in rural Nigeria: Implications for screen‐and‐treat strategies [DOI]
  13. 13 Gynecological malignancies in Aminu Kano Teaching Hospital Kano: A 3 year review [DOI]
  14. 14 Persistence of high‐risk human papillomavirus infection in a population‐based cohort of Danish women [DOI]
  15. 15 Detection and quantitation of HPV in genital and oral tissues and fluids by real time PCR [DOI]
  16. 16 Specimen self‐collection and HPV DNA screening in a pilot study of 100,242 women [DOI]
  17. 17 Evaluation of primers and PCR performance on HPV DNA screening in normal and low grade abnormal cervical cells.
  18. 18 Embracing a new era in cervical cancer screening [DOI]
  19. 19 Classical Molecular Tests Using Urine Samples as a Potential Screening Tool for Human Papillomavirus Detection in Human Immunodeficiency Virus-Infected Women [DOI]
  20. 20 Utilization of Human papillomavirus (HPV) DNA detection for cervical cancer screening in developing countries: A myth or reality [DOI]

Cited by 4

Showing 1 of 4 known citations — external sources report more than can currently be individually listed.

Article metrics

Real usage data collected on this platform.

26

Page views

0

PDF downloads

8

Outbound clicks

4

Citations

Views over time

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

Traffic sources

Referring site, by host.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.